Biogen Forecasts 2024 Adjusted EPS Of $15.00-$16.00 Versus Consensus $15.45, Representing Growth Of Around 5% Versus 2023 At Mid-Point
Portfolio Pulse from Benzinga Newsdesk
Biogen has projected its adjusted EPS for 2024 to be in the range of $15.00-$16.00, indicating an approximate 5% growth from 2023 at the mid-point of this forecast.
February 13, 2024 | 12:13 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Biogen's forecast for 2024 adjusted EPS suggests a positive growth trajectory, indicating a roughly 5% increase from 2023.
Biogen's projection of its 2024 adjusted EPS to be between $15.00 and $16.00, representing about a 5% growth from 2023, is a strong indicator of the company's positive financial outlook and growth trajectory. This forecast is likely to be viewed positively by investors, potentially leading to an increase in stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100